Nano delivery systems in stem cell therapy: Transforming regenerative medicine and overcoming clinical challenges

Aswini Rajendran, Rithi Angelin Rajan, Saranya Balasubramaniyam, Karthikeyan Elumalai
{"title":"Nano delivery systems in stem cell therapy: Transforming regenerative medicine and overcoming clinical challenges","authors":"Aswini Rajendran,&nbsp;Rithi Angelin Rajan,&nbsp;Saranya Balasubramaniyam,&nbsp;Karthikeyan Elumalai","doi":"10.1016/j.ntm.2024.100069","DOIUrl":null,"url":null,"abstract":"<div><div>Stem cell therapy has emerged as a promising approach in regenerative medicine, offering potential treatments for various degenerative diseases and injuries. However, the clinical application of stem cell therapy faces challenges such as low cell viability, inefficient delivery to target sites, and immune rejection. Nanodelivery systems (NDS) have the potential to address these limitations and enhance the efficacy of stem cell-based treatments. This review looks at how NDS can help stem cell therapy work well by creating a safe environment, allowing targeted delivery, and making it easier to control the release of therapeutic factors. The article discusses various types of NDS, including liposomes, polymeric nanoparticles, mesoporous silica nanoparticles, gold nanoparticles, and magnetic nanoparticles, highlighting their unique properties and advantages in stem cell therapy applications. Furthermore, the review examines the potential of NDS in specific areas of regenerative medicine, such as cardiovascular regeneration, neurodegenerative diseases, musculoskeletal tissue repair, and wound healing. The article also addresses the challenges and limitations associated with NDS, such as biocompatibility, toxicity, manufacturing scalability, and regulatory hurdles. Finally, the article explores the future trajectory of nanotechnology in stem cell therapy, discussing the utilization of intelligent nanoparticles, precision genetic modifications, and the benefits of personalized nanomedicine.</div></div>","PeriodicalId":100941,"journal":{"name":"Nano TransMed","volume":"4 ","pages":"Article 100069"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nano TransMed","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2790676024000402","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Stem cell therapy has emerged as a promising approach in regenerative medicine, offering potential treatments for various degenerative diseases and injuries. However, the clinical application of stem cell therapy faces challenges such as low cell viability, inefficient delivery to target sites, and immune rejection. Nanodelivery systems (NDS) have the potential to address these limitations and enhance the efficacy of stem cell-based treatments. This review looks at how NDS can help stem cell therapy work well by creating a safe environment, allowing targeted delivery, and making it easier to control the release of therapeutic factors. The article discusses various types of NDS, including liposomes, polymeric nanoparticles, mesoporous silica nanoparticles, gold nanoparticles, and magnetic nanoparticles, highlighting their unique properties and advantages in stem cell therapy applications. Furthermore, the review examines the potential of NDS in specific areas of regenerative medicine, such as cardiovascular regeneration, neurodegenerative diseases, musculoskeletal tissue repair, and wound healing. The article also addresses the challenges and limitations associated with NDS, such as biocompatibility, toxicity, manufacturing scalability, and regulatory hurdles. Finally, the article explores the future trajectory of nanotechnology in stem cell therapy, discussing the utilization of intelligent nanoparticles, precision genetic modifications, and the benefits of personalized nanomedicine.
纳米输送系统在干细胞治疗:转化再生医学和克服临床挑战
干细胞治疗已经成为再生医学中一个很有前途的方法,为各种退行性疾病和损伤提供了潜在的治疗方法。然而,干细胞治疗的临床应用面临着诸如细胞活力低、靶向部位递送效率低和免疫排斥等挑战。纳米递送系统(NDS)有潜力解决这些限制并提高干细胞治疗的疗效。这篇综述着眼于NDS如何通过创造一个安全的环境,允许靶向递送,并使其更容易控制治疗因子的释放来帮助干细胞治疗更好地工作。本文讨论了NDS的各种类型,包括脂质体、聚合物纳米颗粒、介孔二氧化硅纳米颗粒、金纳米颗粒和磁性纳米颗粒,重点介绍了它们在干细胞治疗中的独特性质和优势。此外,本文还探讨了NDS在再生医学特定领域的潜力,如心血管再生、神经退行性疾病、肌肉骨骼组织修复和伤口愈合。本文还讨论了与NDS相关的挑战和限制,例如生物相容性、毒性、制造可扩展性和监管障碍。最后,本文探讨了纳米技术在干细胞治疗中的未来发展轨迹,讨论了智能纳米粒子的应用,精确的基因修饰,以及个性化纳米医学的好处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信